{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antiviral therapy", "novel coronavirus", "nutraceuticals", "pandemic", "viral infection"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33669456", "DateCompleted": {"Year": "2021", "Month": "03", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "16"}], "Language": ["eng"], "ELocationID": ["1963", "10.3390/ijms22041963"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "22", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Feb", "Day": "16"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Adjunctive Nutraceutical Therapies for COVID-19.", "Abstract": {"AbstractText": ["The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19), is a worldwide pandemic, as declared by the World Health Organization (WHO). It is a respiratory virus that infects people of all ages. Although it may present with mild to no symptoms in most patients, those who are older, immunocompromised, or with multiple comorbidities may present with severe and life-threatening infections. Throughout history, nutraceuticals, such as a variety of phytochemicals from medicinal plants and dietary supplements, have been used as adjunct therapies for many disease conditions, including viral infections. Appropriate use of these adjunct therapies with antiviral proprieties may be beneficial in the treatment and/or prophylaxis of COVID-19. In this review, we provide a comprehensive summary of nutraceuticals, such as vitamins C, D, E, zinc, melatonin, and other phytochemicals and function foods. These nutraceuticals may have potential therapeutic efficacies in fighting the threat of the SARS-CoV-2/COVID-19 pandemic."]}, "AuthorList": [{"Identifier": ["0000-0003-4851-7650"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, University of Maryland, Baltimore, MD 21201, USA."}], "LastName": "Subedi", "ForeName": "Lalita", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Froedtert Hospital, Milwaukee, WI 53226, USA."}], "LastName": "Tchen", "ForeName": "Stephanie", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, University of Maryland, Baltimore, MD 21201, USA."}], "LastName": "Gaire", "ForeName": "Bhakta Prasad", "Initials": "BP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medicine, University of Maryland, Baltimore, MD 21201, USA."}], "LastName": "Hu", "ForeName": "Bingren", "Initials": "B"}, {"Identifier": ["0000-0002-2859-8513"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Division of Pulmonary and Critical Care Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA."}], "LastName": "Hu", "ForeName": "Kurt", "Initials": "K"}], "GrantList": [{"GrantID": "R01 NS129553", "Acronym": "NS", "Agency": "NINDS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Vitamins"}, {"RegistryNumber": "1406-16-2", "NameOfSubstance": "Vitamin D"}, {"RegistryNumber": "1406-18-4", "NameOfSubstance": "Vitamin E"}, {"RegistryNumber": "J41CSQ7QDS", "NameOfSubstance": "Zinc"}, {"RegistryNumber": "JL5DK93RCL", "NameOfSubstance": "Melatonin"}, {"RegistryNumber": "PQ6CK8PD0R", "NameOfSubstance": "Ascorbic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Ascorbic Acid"}, {"QualifierName": ["analysis"], "DescriptorName": "Dietary Supplements"}, {"QualifierName": ["analysis"], "DescriptorName": "Functional Food"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Melatonin"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Vitamin D"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Vitamin E"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Vitamins"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Zinc"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ko W.C., Rolain J.M., Lee N.Y., Chen P.L., Huang C.T., Lee P.I., Hsueh P.R. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int. J. Antimicrob. Agents. 2020;55:105933. doi: 10.1016/j.ijantimicag.2020.105933.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105933", "PMC7135364", "32147516"]}, {"Citation": "COVID-19 Map: Johns Hopkins Coronavirus Resource Center, 2020.  [(accessed on 4 July 2020)]; Available online:  Coronavirus.jhu.edu/map.html."}, {"Citation": "Coronavirus Disease 2019 (COVID-19). FDA.  [(accessed on 12 December 2020)]; Available online:  https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19."}, {"Citation": "Mani J.S., Johnson J.B., Steel J.C., Broszczak D.A., Neilsen P.M., Walsh K.B., Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res. 2020;284:197989. doi: 10.1016/j.virusres.2020.197989.", "ArticleIdList": ["10.1016/j.virusres.2020.197989", "PMC7190535", "32360300"]}, {"Citation": "Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708\u20131720. doi: 10.1056/NEJMoa2002032.", "ArticleIdList": ["10.1056/NEJMoa2002032", "PMC7092819", "32109013"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Martinez M.A. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus. Antimicrob. Agents Chemother. 2020;64 doi: 10.1128/AAC.00399-20.", "ArticleIdList": ["10.1128/AAC.00399-20", "PMC7179632", "32152082"]}, {"Citation": "Assessment of Evidence for COVID-19-Related Treatments. ASHP.  [(accessed on 20 August 2020)]; Available online:  www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx."}, {"Citation": "Xu J., Zhao S., Teng T., Abdalla A.E., Zhu W., Xie L., Wang Y., Guo X. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020;12:244. doi: 10.3390/v12020244.", "ArticleIdList": ["10.3390/v12020244", "PMC7077191", "32098422"]}, {"Citation": "Veeresham C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Technol. Res. 2012;3:200\u2013201. doi: 10.4103/2231-4040.104709.", "ArticleIdList": ["10.4103/2231-4040.104709", "PMC3560124", "23378939"]}, {"Citation": "Varzakas T., Zakynthinos G., Verpoort F. Plant Food Residues as a Source of Nutraceuticals and Functional Foods. Foods. 2016;5:88. doi: 10.3390/foods5040088.", "ArticleIdList": ["10.3390/foods5040088", "PMC5302437", "28231183"]}, {"Citation": "Hamulka J., Jeruszka-Bielak M., Gornicka M., Drywien M.E., Zielinska-Pukos M.A. Dietary Supplements during COVID-19 Outbreak. Results of Google Trends Analysis Supported by PLifeCOVID-19 Online Studies. Nutrients. 2020;13:54. doi: 10.3390/nu13010054.", "ArticleIdList": ["10.3390/nu13010054", "PMC7823317", "33375422"]}, {"Citation": "De Faria Coelho-Ravagnani C., Corgosinho F.C., Sanches F.F.Z., Prado C.M.M., Laviano A., Mota J.F. Dietary recommendations during the COVID-19 pandemic. Nutr. Rev. 2020 doi: 10.1093/nutrit/nuaa067.", "ArticleIdList": ["10.1093/nutrit/nuaa067", "PMC7454801", "32653930"]}, {"Citation": "Dolin R., Hirsch M.S. Remdesivir\u2014An Important First Step. N. Engl. J. Med. 2020 doi: 10.1056/NEJMe2018715.", "ArticleIdList": ["10.1056/NEJMe2018715", "PMC7269011", "32459913"]}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269\u2013271. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Chen P., Nirula A., Heller B., Gottlieb R.L., Boscia J., Morris J., Huhn G., Cardona J., Mocherla B., Stosor V., et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N. Engl. J. Med. 2021;384:229\u2013237. doi: 10.1056/NEJMoa2029849.", "ArticleIdList": ["10.1056/NEJMoa2029849", "PMC7646625", "33113295"]}, {"Citation": "Lammers T., Sofias A.M., van der Meel R., Schiffelers R., Storm G., Tacke F., Koschmieder S., Brummendorf T.H., Kiessling F., Metselaar J.M. Dexamethasone nanomedicines for COVID-19. Nat. Nanotechnol. 2020;15:622\u2013624. doi: 10.1038/s41565-020-0752-z.", "ArticleIdList": ["10.1038/s41565-020-0752-z", "PMC7116110", "32747742"]}, {"Citation": "Group R.C., Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., et al. Dexamethasone in Hospitalized Patients with Covid-19\u2014Preliminary Report. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2021436.", "ArticleIdList": ["10.1056/NEJMoa2021436", "PMC7383595", "32678530"]}, {"Citation": "Luo P., Liu Y., Qiu L., Liu X., Liu D., Li J. Tocilizumab treatment in COVID-19: A single center experience. J. Med. Virol. 2020;92:814\u2013818. doi: 10.1002/jmv.25801.", "ArticleIdList": ["10.1002/jmv.25801", "PMC7262125", "32253759"]}, {"Citation": "Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P., Liu X., Zhao L., Dong E., Song C., et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Clin. Infect. Dis. 2020;71:732\u2013739. doi: 10.1093/cid/ciaa237.", "ArticleIdList": ["10.1093/cid/ciaa237", "PMC7108130", "32150618"]}, {"Citation": "Bleyzac N., Goutelle S., Bourguignon L., Tod M. Azithromycin for COVID-19: More Than Just an Antimicrobial? Clin. Drug Investig. 2020;40:683\u2013686. doi: 10.1007/s40261-020-00933-3.", "ArticleIdList": ["10.1007/s40261-020-00933-3", "PMC7290142", "32533455"]}, {"Citation": "Liu X., Li Z., Liu S., Sun J., Chen Z., Jiang M., Zhang Q., Wei Y., Wang X., Huang Y.Y., et al. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm. Sin. B. 2020;10:1205\u20131215. doi: 10.1016/j.apsb.2020.04.008.", "ArticleIdList": ["10.1016/j.apsb.2020.04.008", "PMC7169892", "32318327"]}, {"Citation": "Liang H., Acharya G. Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow? Acta Obstet. Gynecol. Scand. 2020;99:439\u2013442. doi: 10.1111/aogs.13836.", "ArticleIdList": ["10.1111/aogs.13836", "32141062"]}, {"Citation": "Dong L., Hu S., Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19) Drug Discov. Ther. 2020;14:58\u201360. doi: 10.5582/ddt.2020.01012.", "ArticleIdList": ["10.5582/ddt.2020.01012", "32147628"]}, {"Citation": "Kalil A.C., Patterson T.F., Mehta A.K., Tomashek K.M., Wolfe C.R., Ghazaryan V., Marconi V.C., Ruiz-Palacios G.M., Hsieh L., Kline S., et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2031994.", "ArticleIdList": ["10.1056/NEJMoa2031994", "PMC7745180", "33306283"]}, {"Citation": "FDA3.  [(accessed on 5 February 2021)]; Available online:  https://www.fda.gov/media/143822/download."}, {"Citation": "Yamamoto N., Yang R., Yoshinaka Y., Amari S., Nakano T., Cinatl J., Rabenau H., Doerr H.W., Hunsmann G., Otaka A., et al. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem. Biophys. Res. Commun. 2004;318:719\u2013725. doi: 10.1016/j.bbrc.2004.04.083.", "ArticleIdList": ["10.1016/j.bbrc.2004.04.083", "PMC7111005", "15144898"]}, {"Citation": "Dexamethasone|Coronavirus Disease COVID-19. COVID-19 Treatment Guidelines, 2020.  [(accessed on 20 August 2020)]; Available online:  www.covid19treatmentguidelines.nih.gov/dexamethasone/"}, {"Citation": "Low-Cost Dexamethasone Reduces Death by up to One Third in Hospitalised Patients with Severe Respiratory Complications of COVID-19\u2014RECOVERY Trial. Www.Recoverytrial.Net, 2020.  [(accessed on 23 July 2020)]; Available online:  www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19."}, {"Citation": "Tomazini B.M., Maia I.S., Cavalcanti A.B., Berwanger O., Rosa R.G., Veiga V.C., Avezum A., Lopes R.D., Bueno F.R., Silva M., et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020;324:1307\u20131316. doi: 10.1001/jama.2020.17021.", "ArticleIdList": ["10.1001/jama.2020.17021", "PMC7489411", "32876695"]}, {"Citation": "Duan K., Liu B., Li C., Zhang H., Yu T., Qu J., Zhou M., Chen L., Meng S., Hu Y., et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc. Natl. Acad. Sci. USA. 2020;117:9490\u20139496. doi: 10.1073/pnas.2004168117.", "ArticleIdList": ["10.1073/pnas.2004168117", "PMC7196837", "32253318"]}, {"Citation": "Rojas M., Rodriguez Y., Monsalve D.M., Acosta-Ampudia Y., Camacho B., Gallo J.E., Rojas-Villarraga A., Ramirez-Santana C., Diaz-Coronado J.C., Manrique R., et al. Convalescent plasma in Covid-19: Possible mechanisms of action. Autoimmun. Rev. 2020;19:102554. doi: 10.1016/j.autrev.2020.102554.", "ArticleIdList": ["10.1016/j.autrev.2020.102554", "PMC7198427", "32380316"]}, {"Citation": "Recommendations for Investigational COVID-19 Convalescent Plasma. FDA.  [(accessed on 23 July 2020)]; Available online:  www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma."}, {"Citation": "Li L., Zhang W., Hu Y., Tong X., Zheng S., Yang J., Kong Y., Ren L., Wei Q., Mei H., et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA. 2020;324:460\u2013470. doi: 10.1001/jama.2020.10044.", "ArticleIdList": ["10.1001/jama.2020.10044", "PMC7270883", "32492084"]}, {"Citation": "Simonovich V.A., Burgos Pratx L.D., Scibona P., Beruto M.V., Vallone M.G., Vazquez C., Savoy N., Giunta D.H., Perez L.G., Sanchez M.D.L., et al. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2031304.", "ArticleIdList": ["10.1056/NEJMoa2031304", "PMC7722692", "33232588"]}, {"Citation": "Libster R., Perez Marc G., Wappner D., Coviello S., Bianchi A., Braem V., Esteban I., Caballero M.T., Wood C., Berrueta M., et al. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults. N. Engl. J. Med. 2021 doi: 10.1056/NEJMoa2033700.", "ArticleIdList": ["10.1056/NEJMoa2033700", "PMC7793608", "33406353"]}, {"Citation": "IDSA.  [(accessed on 8 January 2021)]; Available online:  https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v3.6.0.pdf."}, {"Citation": "Zhao Q., He Y. Challenges of Convalescent Plasma Therapy on COVID-19. J. Clin. Virol. 2020;127:104358. doi: 10.1016/j.jcv.2020.104358.", "ArticleIdList": ["10.1016/j.jcv.2020.104358", "PMC7146649", "32305026"]}, {"Citation": "FDA.  [(accessed on 5 February 2021)]; Available online:  https://www.fda.gov/media/143602/download."}, {"Citation": "1, F.  [(accessed on 5 February 2021)]; Available online:  https://www.fda.gov/media/144412/download."}, {"Citation": "FDA2.  [(accessed on 5 February 2021)]; Available online:  https://www.fda.gov/media/144636/download."}, {"Citation": "Hermine O., Mariette X., Tharaux P.L., Resche-Rigon M., Porcher R., Ravaud P., Group C.-C. Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. JAMA Intern. Med. 2021;181:32\u201340. doi: 10.1001/jamainternmed.2020.6820.", "ArticleIdList": ["10.1001/jamainternmed.2020.6820", "PMC7577198", "33080017"]}, {"Citation": "Salvarani C., Dolci G., Massari M., Merlo D.F., Cavuto S., Savoldi L., Bruzzi P., Boni F., Braglia L., Turra C., et al. Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern. Med. 2021;181:24\u201331. doi: 10.1001/jamainternmed.2020.6615.", "ArticleIdList": ["10.1001/jamainternmed.2020.6615", "PMC7577199", "33080005"]}, {"Citation": "Cavalcanti A.B., Zampieri F.G., Rosa R.G., Azevedo L.C.P., Veiga V.C., Avezum A., Damiani L.P., Marcadenti A., Kawano-Dourado L., Lisboa T., et al. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N. Engl. J. Med. 2020;383:2041\u20132052. doi: 10.1056/NEJMoa2019014.", "ArticleIdList": ["10.1056/NEJMoa2019014", "PMC7397242", "32706953"]}, {"Citation": "Self W.H., Semler M.W., Leither L.M., Casey J.D., Angus D.C., Brower R.G., Chang S.Y., Collins S.P., Eppensteiner J.C., Filbin M.R., et al. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020;324:2165\u20132176. doi: 10.1001/jama.2020.22240.", "ArticleIdList": ["10.1001/jama.2020.22240", "PMC7653542", "33165621"]}, {"Citation": "Ulrich R.J., Troxel A.B., Carmody E., Eapen J., Backer M., DeHovitz J.A., Prasad P.J., Li Y., Delgado C., Jrada M., et al. Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients. Open Forum. Infect. Dis. 2020;7:ofaa446. doi: 10.1093/ofid/ofaa446.", "ArticleIdList": ["10.1093/ofid/ofaa446", "PMC7543602", "33134417"]}, {"Citation": "Abella B.S., Jolkovsky E.L., Biney B.T., Uspal J.E., Hyman M.C., Frank I., Hensley S.E., Gill S., Vogl D.T., Maillard I., et al. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA Intern. Med. 2021;181:195\u2013202. doi: 10.1001/jamainternmed.2020.6319.", "ArticleIdList": ["10.1001/jamainternmed.2020.6319", "PMC7527945", "33001138"]}, {"Citation": "Feder H.M., Jr., Renfro L., Schmidt D.D. Common questions about herpes simplex. Hosp. Pract. (Off. Ed.) 1989;24:50\u201352, 55\u201356, 61\u201352.", "ArticleIdList": ["2492293"]}, {"Citation": "Cipriani A., Zorzi A., Ceccato D., Capone F., Parolin M., Donato F., Fioretto P., Pesavento R., Previato L., Maffei P., et al. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin. Int. J. Cardiol. 2020;316:280\u2013284. doi: 10.1016/j.ijcard.2020.05.036.", "ArticleIdList": ["10.1016/j.ijcard.2020.05.036", "PMC7235573", "32439366"]}, {"Citation": "Chen F., Chan K.H., Jiang Y., Kao R.Y., Lu H.T., Fan K.W., Cheng V.C., Tsui W.H., Hung I.F., Lee T.S., et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J. Clin. Virol. 2004;31:69\u201375. doi: 10.1016/j.jcv.2004.03.003.", "ArticleIdList": ["10.1016/j.jcv.2004.03.003", "PMC7128415", "15288617"]}, {"Citation": "Chan J.F., Yao Y., Yeung M.L., Deng W., Bao L., Jia L., Li F., Xiao C., Gao H., Yu P., et al. Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J. Infect. Dis. 2015;212:1904\u20131913. doi: 10.1093/infdis/jiv392.", "ArticleIdList": ["10.1093/infdis/jiv392", "PMC7107395", "26198719"]}, {"Citation": "Chu C.M., Cheng V.C., Hung I.F., Wong M.M., Chan K.H., Chan K.S., Kao R.Y., Poon L.L., Wong C.L., Guan Y., et al. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax. 2004;59:252\u2013256. doi: 10.1136/thorax.2003.012658.", "ArticleIdList": ["10.1136/thorax.2003.012658", "PMC1746980", "14985565"]}, {"Citation": "Kim U.J., Won E.J., Kee S.J., Jung S.I., Jang H.C. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome. Antivir. Ther. 2016;21:455\u2013459. doi: 10.3851/IMP3002.", "ArticleIdList": ["10.3851/IMP3002", "26492219"]}, {"Citation": "Hung I.F., Lung K.C., Tso E.Y., Liu R., Chung T.W., Chu M.Y., Ng Y.Y., Lo J., Chan J., Tam A.R., et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial. Lancet. 2020;395:1695\u20131704. doi: 10.1016/S0140-6736(20)31042-4.", "ArticleIdList": ["10.1016/S0140-6736(20)31042-4", "PMC7211500", "32401715"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M., et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N. Engl. J. Med. 2020;382:1787\u20131799. doi: 10.1056/NEJMoa2001282.", "ArticleIdList": ["10.1056/NEJMoa2001282", "PMC7121492", "32187464"]}, {"Citation": "Group R.C. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet. 2020 doi: 10.1016/S0140-6736(20)32013-4.", "ArticleIdList": ["10.1016/S0140-6736(20)32013-4", "PMC7535623", "33031764"]}, {"Citation": "Consortium W.H.O.S.T., Pan H., Peto R., Henao-Restrepo A.M., Preziosi M.P., Sathiyamoorthy V., Abdool Karim Q., Alejandria M.M., Hernandez Garcia C., Kieny M.P., et al. Repurposed Antiviral Drugs for Covid-19\u2014Interim WHO Solidarity Trial Results. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2023184.", "ArticleIdList": ["10.1056/NEJMoa2023184", "PMC7727327", "33264556"]}, {"Citation": "Rocco P.R.M., Silva P.L., Cruz F.F., Junior M., Tierno P., Moura M.A., De Oliveira L.F.G., Lima C.C., Dos Santos E.A., Junior W.F., et al. Early use of nitazoxanide in mild Covid-19 disease: Randomised, placebo-controlled trial. Eur. Respir. J. 2021 doi: 10.1183/13993003.03725-2020.", "ArticleIdList": ["10.1183/13993003.03725-2020", "PMC7758778", "33361100"]}, {"Citation": "Shereen M.A., Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91\u201398. doi: 10.1016/j.jare.2020.03.005.", "ArticleIdList": ["10.1016/j.jare.2020.03.005", "PMC7113610", "32257431"]}, {"Citation": "Kalra E.K. Nutraceutical--definition and introduction. AAPS Pharm.Sci. 2003;5:E25. doi: 10.1208/ps050325.", "ArticleIdList": ["10.1208/ps050325", "PMC2750935", "14621960"]}, {"Citation": "Das L., Bhaumik E., Raychaudhuri U., Chakraborty R. Role of nutraceuticals in human health. J. Food Sci. Technol. 2012;49:173\u2013183. doi: 10.1007/s13197-011-0269-4.", "ArticleIdList": ["10.1007/s13197-011-0269-4", "PMC3550857", "23572839"]}, {"Citation": "Carr A.C. Micronutrient status of COVID-19 patients: A critical consideration. Crit Care. 2020;24:349. doi: 10.1186/s13054-020-03085-0.", "ArticleIdList": ["10.1186/s13054-020-03085-0", "PMC7296900", "32546195"]}, {"Citation": "Yoon G.A., Yeum K.J., Cho Y.S., Chen C.Y., Tang G., Blumberg J.B., Russell R.M., Yoon S., Lee-Kim Y.C. Carotenoids and total phenolic contents in plant foods commonly consumed in Korea. Nutr. Res. Pract. 2012;6:481\u2013490. doi: 10.4162/nrp.2012.6.6.481.", "ArticleIdList": ["10.4162/nrp.2012.6.6.481", "PMC3542437", "23346297"]}, {"Citation": "Kuhn S.O., Meissner K., Mayes L.M., Bartels K. Vitamin C in sepsis. Curr. Opin. Anaesthesiol. 2018;31:55\u201360. doi: 10.1097/ACO.0000000000000549.", "ArticleIdList": ["10.1097/ACO.0000000000000549", "PMC5996765", "29176375"]}, {"Citation": "Mandl J., Szarka A., Banhegyi G. Vitamin C: Update on physiology and pharmacology. Br. J. Pharmacol. 2009;157:1097\u20131110. doi: 10.1111/j.1476-5381.2009.00282.x.", "ArticleIdList": ["10.1111/j.1476-5381.2009.00282.x", "PMC2743829", "19508394"]}, {"Citation": "Colunga Biancatelli R.M.L., Berrill M., Marik P.E. The antiviral properties of vitamin C. Expert Rev. Anti Infect. Ther. 2020;18:99\u2013101. doi: 10.1080/14787210.2020.1706483.", "ArticleIdList": ["10.1080/14787210.2020.1706483", "31852327"]}, {"Citation": "Hemila H., Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst. Rev. 2013 doi: 10.1002/14651858.CD000980.pub4.", "ArticleIdList": ["10.1002/14651858.CD000980.pub4", "PMC8078152", "23440782"]}, {"Citation": "Kim H., Jang M., Kim Y., Choi J., Jeon J., Kim J., Hwang Y.I., Kang J.S., Lee W.J. Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection. J. Pharm. Pharmacol. 2016;68:406\u2013420. doi: 10.1111/jphp.12529.", "ArticleIdList": ["10.1111/jphp.12529", "26898166"]}, {"Citation": "Schencking M., Vollbracht C., Weiss G., Lebert J., Biller A., Goyvaerts B., Kraft K. Intravenous vitamin C in the treatment of shingles: Results of a multicenter prospective cohort study. Med. Sci. Monit. 2012;18:CR215-224. doi: 10.12659/MSM.882621.", "ArticleIdList": ["10.12659/MSM.882621", "PMC3560828", "22460093"]}, {"Citation": "Liu F., Zhu Y., Zhang J., Li Y., Peng Z. Intravenous high-dose vitamin C for the treatment of severe COVID-19: Study protocol for a multicentre randomised controlled trial. BMJ Open. 2020;10:e039519. doi: 10.1136/bmjopen-2020-039519.", "ArticleIdList": ["10.1136/bmjopen-2020-039519", "PMC7348463", "32641343"]}, {"Citation": "Marik P.E., Khangoora V., Rivera R., Hooper M.H., Catravas J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2017;151:1229\u20131238. doi: 10.1016/j.chest.2016.11.036.", "ArticleIdList": ["10.1016/j.chest.2016.11.036", "27940189"]}, {"Citation": "Fowler A.A., 3rd, Truwit J.D., Hite R.D., Morris P.E., DeWilde C., Priday A., Fisher B., Thacker L.R., 2nd, Natarajan R., Brophy D.F., et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019;322:1261\u20131270. doi: 10.1001/jama.2019.11825.", "ArticleIdList": ["10.1001/jama.2019.11825", "PMC6777268", "31573637"]}, {"Citation": "Rizvi S., Raza S.T., Ahmed F., Ahmad A., Abbas S., Mahdi F. The role of vitamin e in human health and some diseases. Sultan Qaboos Univ. Med. J. 2014;14:e157\u2013e165.", "ArticleIdList": ["PMC3997530", "24790736"]}, {"Citation": "Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006;134:1129\u20131140. doi: 10.1017/S0950268806007175.", "ArticleIdList": ["10.1017/S0950268806007175", "PMC2870528", "16959053"]}, {"Citation": "Mitchell F. Vitamin-D and COVID-19: Do deficient risk a poorer outcome? Lancet Diabetes Endocrinol. 2020;8:570. doi: 10.1016/S2213-8587(20)30183-2.", "ArticleIdList": ["10.1016/S2213-8587(20)30183-2", "PMC7239633", "32445630"]}, {"Citation": "Zhou Y.F., Luo B.A., Qin L.L. The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine. 2019;98:e17252. doi: 10.1097/MD.0000000000017252.", "ArticleIdList": ["10.1097/MD.0000000000017252", "PMC6756683", "31567995"]}, {"Citation": "Martineau A.R., Jolliffe D.A., Hooper R.L., Greenberg L., Aloia J.F., Bergman P., Dubnov-Raz G., Esposito S., Ganmaa D., Ginde A.A., et al. Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. doi: 10.1136/bmj.i6583.", "ArticleIdList": ["10.1136/bmj.i6583", "PMC5310969", "28202713"]}, {"Citation": "Grant W.B., Lahore H., McDonnell S.L., Baggerly C.A., French C.B., Aliano J.L., Bhattoa H.P. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12:988. doi: 10.3390/nu12040988.", "ArticleIdList": ["10.3390/nu12040988", "PMC7231123", "32252338"]}, {"Citation": "Daneshkhah A., Agrawal V., Eshein A., Subramanian H., Roy H.K., Backman V. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients. Aging Clin. Exp. Res. 2020;32:2141\u20132158. doi: 10.1007/s40520-020-01677-y.", "ArticleIdList": ["10.1007/s40520-020-01677-y", "PMC7465887", "32876941"]}, {"Citation": "Marcinowska-Suchowierska E., Kupisz-Urbanska M., Lukaszkiewicz J., Pludowski P., Jones G. Vitamin D Toxicity-A Clinical Perspective. Front. Endocrinol. 2018;9:550. doi: 10.3389/fendo.2018.00550.", "ArticleIdList": ["10.3389/fendo.2018.00550", "PMC6158375", "30294301"]}, {"Citation": "Kumar A., Kubota Y., Chernov M., Kasuya H. Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Med. Hypotheses. 2020;144:109848. doi: 10.1016/j.mehy.2020.109848.", "ArticleIdList": ["10.1016/j.mehy.2020.109848", "PMC7247509", "32512490"]}, {"Citation": "Rahman M.T., Idid S.Z. Can Zn Be a Critical Element in COVID-19 Treatment? Biol. Trace Elem. Res. 2020 doi: 10.1007/s12011-020-02194-9.", "ArticleIdList": ["10.1007/s12011-020-02194-9", "PMC7250542", "32458149"]}, {"Citation": "Ibs K.H., Rink L. Zinc-altered immune function. J. Nutr. 2003;133:1452S\u20131456S. doi: 10.1093/jn/133.5.1452S.", "ArticleIdList": ["10.1093/jn/133.5.1452S", "12730441"]}, {"Citation": "Te Velthuis A.J., van den Worm S.H., Sims A.C., Baric R.S., Snijder E.J., van Hemert M.J. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6:e1001176. doi: 10.1371/journal.ppat.1001176.", "ArticleIdList": ["10.1371/journal.ppat.1001176", "PMC2973827", "21079686"]}, {"Citation": "Shittu M.O., Afolami O.I. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives\u2014A better synergy for future COVID-19 clinical trials. Infez Med. 2020;28:192\u2013197.", "ArticleIdList": ["32335560"]}, {"Citation": "Finzi E. Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients. Int. J. Infect. Dis. 2020;99:307\u2013309. doi: 10.1016/j.ijid.2020.06.006.", "ArticleIdList": ["10.1016/j.ijid.2020.06.006", "PMC7834648", "32522597"]}, {"Citation": "Jothimani D., Kailasam E., Danielraj S., Nallathambi B., Ramachandran H., Sekar P., Manoharan S., Ramani V., Narasimhan G., Kaliamoorthy I., et al. COVID-19: Poor outcomes in patients with zinc deficiency. Int. J. Infect. Dis. 2020;100:343\u2013349. doi: 10.1016/j.ijid.2020.09.014.", "ArticleIdList": ["10.1016/j.ijid.2020.09.014", "PMC7482607", "32920234"]}, {"Citation": "Zhang R., Wang X., Ni L., Di X., Ma B., Niu S., Liu C., Reiter R.J. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583. doi: 10.1016/j.lfs.2020.117583.", "ArticleIdList": ["10.1016/j.lfs.2020.117583", "PMC7102583", "32217117"]}, {"Citation": "Boga J.A., Coto-Montes A., Rosales-Corral S.A., Tan D.X., Reiter R.J. Beneficial actions of melatonin in the management of viral infections: A new use for this \u201cmolecular handyman\u201d? Rev. Med. Virol. 2012;22:323\u2013338. doi: 10.1002/rmv.1714.", "ArticleIdList": ["10.1002/rmv.1714", "PMC7169144", "22511571"]}, {"Citation": "Dietary Supplement Manufacturing\u2014USP Verified Mark|USP.  [(accessed on 20 August 2020)]; Available online:  www.usp.org/verification-services/verified-mark."}, {"Citation": "From the American Association of Neurological Surgeons. American Society of Neuroradiology. Cardiovascular and Interventional Radiology Society of Europe. World Stroke Organization. Sacks D., Baxter B., Campbell B.C.V., Carpenter J.S., Cognard C., Dippel D., et al. Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke. Int. J. Stroke. 2018;13:612\u2013632. doi: 10.1016/j.jvir.2017.11.026.", "ArticleIdList": ["10.1016/j.jvir.2017.11.026", "29786478"]}, {"Citation": "Alkhatib A., Tsang C., Tiss A., Bahorun T., Arefanian H., Barake R., Khadir A., Tuomilehto J. Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management. Nutrients. 2017;9:1310. doi: 10.3390/nu9121310.", "ArticleIdList": ["10.3390/nu9121310", "PMC5748760", "29194424"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046. doi: 10.1016/S0140-6736(03)13615-X.", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., Bielenberg J. Antiviral effects of Glycyrrhiza species. Phytother. Res. 2008;22:141\u2013148. doi: 10.1002/ptr.2295.", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Li S.Y., Chen C., Zhang H.Q., Guo H.Y., Wang H., Wang L., Zhang X., Hua S.N., Yu J., Xiao P.G., et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir. Res. 2005;67:18\u201323. doi: 10.1016/j.antiviral.2005.02.007.", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Lin C.W., Tsai F.J., Tsai C.H., Lai C.C., Wan L., Ho T.Y., Hsieh C.C., Chao P.D. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antivir. Res. 2005;68:36\u201342. doi: 10.1016/j.antiviral.2005.07.002.", "ArticleIdList": ["10.1016/j.antiviral.2005.07.002", "PMC7114321", "16115693"]}, {"Citation": "Ryu Y.B., Jeong H.J., Kim J.H., Kim Y.M., Park J.Y., Kim D., Nguyen T.T., Park S.J., Chang J.S., Park K.H., et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg. Med. Chem. 2010;18:7940\u20137947. doi: 10.1016/j.bmc.2010.09.035.", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Lau K.M., Lee K.M., Koon C.M., Cheung C.S., Lau C.P., Ho H.M., Lee M.Y., Au S.W., Cheng C.H., Lau C.B., et al. Immunomodulatory and anti-SARS activities of Houttuynia cordata. J. Ethnopharmacol. 2008;118:79\u201385. doi: 10.1016/j.jep.2008.03.018.", "ArticleIdList": ["10.1016/j.jep.2008.03.018", "PMC7126383", "18479853"]}, {"Citation": "Wu C.Y., Jan J.T., Ma S.H., Kuo C.J., Juan H.F., Cheng Y.S., Hsu H.H., Huang H.C., Wu D., Brik A., et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. USA. 2004;101:10012\u201310017. doi: 10.1073/pnas.0403596101.", "ArticleIdList": ["10.1073/pnas.0403596101", "PMC454157", "15226499"]}, {"Citation": "Luo W., Su X., Gong S., Qin Y., Liu W., Li J., Yu H., Xu Q. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci. Trends. 2009;3:124\u2013126.", "ArticleIdList": ["20103835"]}, {"Citation": "Kim D.E., Min J.S., Jang M.S., Lee J.Y., Shin Y.S., Song J.H., Kim H.R., Kim S., Jin Y.H., Kwon S. Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells. Biomolecules. 2019;9:696. doi: 10.3390/biom9110696.", "ArticleIdList": ["10.3390/biom9110696", "PMC6921063", "31690059"]}, {"Citation": "Sirtori C.R. Aescin: Pharmacology, pharmacokinetics and therapeutic profile. Pharmacol. Res. 2001;44:183\u2013193. doi: 10.1006/phrs.2001.0847.", "ArticleIdList": ["10.1006/phrs.2001.0847", "11529685"]}, {"Citation": "Cheng P.W., Ng L.T., Chiang L.C., Lin C.C. Antiviral effects of saikosaponins on human coronavirus 229E in vitro. Clin. Exp. Pharmacol. Physiol. 2006;33:612\u2013616. doi: 10.1111/j.1440-1681.2006.04415.x.", "ArticleIdList": ["10.1111/j.1440-1681.2006.04415.x", "PMC7162031", "16789928"]}, {"Citation": "Jo S., Kim S., Shin D.H., Kim M.S. Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzym. Inhib. Med. Chem. 2020;35:145\u2013151. doi: 10.1080/14756366.2019.1690480.", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Veeramani C., Alsaif M.A., Al-Numair K.S. Herbacetin, a flaxseed flavonoid, ameliorates high percent dietary fat induced insulin resistance and lipid accumulation through the regulation of hepatic lipid metabolizing and lipid-regulating enzymes. Chem. Biol. Interact. 2018;288:49\u201356. doi: 10.1016/j.cbi.2018.04.009.", "ArticleIdList": ["10.1016/j.cbi.2018.04.009", "29653099"]}, {"Citation": "Lim H., Son K.H., Chang H.W., Bae K., Kang S.S., Kim H.P. Anti-inflammatory activity of pectolinarigenin and pectolinarin isolated from Cirsium chanroenicum. Biol. Pharm. Bull. 2008;31:2063\u20132067. doi: 10.1248/bpb.31.2063.", "ArticleIdList": ["10.1248/bpb.31.2063", "18981574"]}, {"Citation": "Wen C.C., Shyur L.F., Jan J.T., Liang P.H., Kuo C.J., Arulselvan P., Wu J.B., Kuo S.C., Yang N.S. Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J. Tradit. Complementary Med. 2011;1:41\u201350. doi: 10.1016/S2225-4110(16)30055-4.", "ArticleIdList": ["10.1016/S2225-4110(16)30055-4", "PMC3942999", "24716104"]}, {"Citation": "Yu M.S., Lee J., Lee J.M., Kim Y., Chin Y.W., Jee J.G., Keum Y.S., Jeong Y.J. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 2012;22:4049\u20134054. doi: 10.1016/j.bmcl.2012.04.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Schwarz S., Sauter D., Wang K., Zhang R., Sun B., Karioti A., Bilia A.R., Efferth T., Schwarz W. Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med. 2014;80:177\u2013182. doi: 10.1055/s-0033-1360277.", "ArticleIdList": ["10.1055/s-0033-1360277", "PMC7171712", "24458263"]}, {"Citation": "Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., Zhang H., Luo H., Zhu L., Jiang P., et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 2004;78:11334\u201311339. doi: 10.1128/JVI.78.20.11334-11339.2004.", "ArticleIdList": ["10.1128/JVI.78.20.11334-11339.2004", "PMC521800", "15452254"]}, {"Citation": "Chang F.R., Yen C.T., Ei-Shazly M., Lin W.H., Yen M.H., Lin K.H., Wu Y.C. Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia. Nat. Prod. Commun. 2012;7:1415\u20131417. doi: 10.1177/1934578X1200701103.", "ArticleIdList": ["10.1177/1934578X1200701103", "23285797"]}, {"Citation": "Osborn D.A., Sinn J. Soy formula for prevention of allergy and food intolerance in infants. Cochrane Database Syst. Rev. 2004 doi: 10.1002/14651858.CD003741.pub2.", "ArticleIdList": ["10.1002/14651858.CD003741.pub2", "15266499"]}, {"Citation": "Chen C.J., Michaelis M., Hsu H.K., Tsai C.C., Yang K.D., Wu Y.C., Cinatl J., Jr., Doerr H.W. Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. J. Ethnopharmacol. 2008;120:108\u2013111. doi: 10.1016/j.jep.2008.07.048.", "ArticleIdList": ["10.1016/j.jep.2008.07.048", "PMC7127248", "18762235"]}, {"Citation": "Jo S., Kim H., Kim S., Shin D.H., Kim M.S. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem. Biol. Drug Des. 2019;94:2023\u20132030. doi: 10.1111/cbdd.13604.", "ArticleIdList": ["10.1111/cbdd.13604", "PMC7162010", "31436895"]}, {"Citation": "Fernandez-Lopez J.A., Almela L., Obon J.M., Castellar R. Determination of antioxidant constituents in cactus pear fruits. Plant Foods Hum. Nutr. 2010;65:253\u2013259. doi: 10.1007/s11130-010-0189-x.", "ArticleIdList": ["10.1007/s11130-010-0189-x", "20811778"]}, {"Citation": "Yang F., Zhang Y., Tariq A., Jiang X., Ahmed Z., Zhihao Z., Idrees M., Azizullah A., Adnan M., Bussmann R.W. Food as medicine: A possible preventive measure against coronavirus disease (COVID-19) Phytother. Res. 2020 doi: 10.1002/ptr.6770.", "ArticleIdList": ["10.1002/ptr.6770", "PMC7283886", "32468635"]}, {"Citation": "Chen C.N., Lin C.P., Huang K.K., Chen W.C., Hsieh H.P., Liang P.H., Hsu J.T. Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3\u2019-digallate (TF3) Evid. Based Complementary Altern. Med. 2005;2:209\u2013215. doi: 10.1093/ecam/neh081.", "ArticleIdList": ["10.1093/ecam/neh081", "PMC1142193", "15937562"]}, {"Citation": "Chang J.S., Wang K.C., Yeh C.F., Shieh D.E., Chiang L.C. Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J. Ethnopharmacol. 2013;145:146\u2013151. doi: 10.1016/j.jep.2012.10.043.", "ArticleIdList": ["10.1016/j.jep.2012.10.043", "23123794"]}, {"Citation": "Watanabe K., Rahmasari R., Matsunaga A., Haruyama T., Kobayashi N. Anti-influenza viral effects of honey in vitro: Potent high activity of manuka honey. Arch. Med. Res. 2014;45:359\u2013365. doi: 10.1016/j.arcmed.2014.05.006.", "ArticleIdList": ["10.1016/j.arcmed.2014.05.006", "24880005"]}, {"Citation": "Nikolaeva-Glomb L., Mukova L., Nikolova N., Badjakov I., Dincheva I., Kondakova V., Doumanova L., Galabov A.S. In vitro antiviral activity of a series of wild berry fruit extracts against representatives of Picorna-, Orthomyxo- and Paramyxoviridae. Nat. Prod. Commun. 2014;9:51\u201354. doi: 10.1177/1934578X1400900116.", "ArticleIdList": ["10.1177/1934578X1400900116", "24660461"]}, {"Citation": "Turmagambetova A.S., Sokolova N.S., Bogoyavlenskiy A.P., Berezin V.E., Lila M.A., Cheng D.M., Dushenkov V. New functionally-enhanced soy proteins as food ingredients with anti-viral activity. Virusdisease. 2015;26:123\u2013132. doi: 10.1007/s13337-015-0268-6.", "ArticleIdList": ["10.1007/s13337-015-0268-6", "PMC4571592", "26396978"]}, {"Citation": "Muller L., Meyer M., Bauer R.N., Zhou H., Zhang H., Jones S., Robinette C., Noah T.L., Jaspers I. Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study. PLoS ONE. 2016;11:e0147742. doi: 10.1371/journal.pone.0147742.", "ArticleIdList": ["10.1371/journal.pone.0147742", "PMC4731143", "26820305"]}, {"Citation": "Chu D.K., Akl E.A., Duda S., Solo K., Yaacoub S., Schunemann H.J. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. Lancet. 2020;395:1973\u20131987. doi: 10.1016/S0140-6736(20)31142-9.", "ArticleIdList": ["10.1016/S0140-6736(20)31142-9", "PMC7263814", "32497510"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "9"}, {"Year": "2021", "Month": "2", "Day": "8"}, {"Year": "2021", "Month": "2", "Day": "8"}, {"Year": "2021", "Month": "3", "Day": "6", "Hour": "1", "Minute": "4"}, {"Year": "2021", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["33669456", "PMC7920448", "10.3390/ijms22041963", "ijms22041963"]}}], "PubmedBookArticle": []}